Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.

Circulation

Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M.
PMID: 34806902
Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22.

BACKGROUND: Remodeling of the extracellular matrix (ECM) is a hallmark of heart failure (HF). Our previous analysis of the secretome of murine cardiac fibroblasts returned ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) as one of the most...

Cite
Barallobre-Barreiro J, Radovits T, Fava M, et al. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021;144(25):2021-2034doi: 10.1161/CIRCULATIONAHA.121.055732.
Barallobre-Barreiro, J., Radovits, T., Fava, M., Mayr, U., Lin, W. Y., Ermolaeva, E., Martínez-López, D., Lindberg, E. L., Duregotti, E., Daróczi, L., Hasman, M., Schmidt, L. E., Singh, B., Lu, R., Baig, F., Siedlar, A. M., Cuello, F., Catibog, N., Theofilatos, K., Shah, A. M., Crespo-Leiro, M. G., Doménech, N., Hübner, N., Merkely, B., & Mayr, M. (2021). Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation, 144(25), 2021-2034. https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro, Javier, et al. "Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling." Circulation vol. 144,25 (2021): 2021-2034. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22. PMID: 34806902; PMCID: PMC8687617.
Copy Download .nbib Format: NLM
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.

Circulation

Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M.
PMID: 34806902
Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22.

BACKGROUND: Remodeling of the extracellular matrix (ECM) is a hallmark of heart failure (HF). Our previous analysis of the secretome of murine cardiac fibroblasts returned ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) as one of the most...

Cite
Barallobre-Barreiro J, Radovits T, Fava M, et al. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021;144(25):2021-2034doi: 10.1161/CIRCULATIONAHA.121.055732.
Barallobre-Barreiro, J., Radovits, T., Fava, M., Mayr, U., Lin, W. Y., Ermolaeva, E., Martínez-López, D., Lindberg, E. L., Duregotti, E., Daróczi, L., Hasman, M., Schmidt, L. E., Singh, B., Lu, R., Baig, F., Siedlar, A. M., Cuello, F., Catibog, N., Theofilatos, K., Shah, A. M., Crespo-Leiro, M. G., Doménech, N., Hübner, N., Merkely, B., & Mayr, M. (2021). Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation, 144(25), 2021-2034. https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro, Javier, et al. "Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling." Circulation vol. 144,25 (2021): 2021-2034. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22. PMID: 34806902.
Copy Download .nbib Format: NLM
Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder.

Korean journal of urology

Igawa Y, Aizawa N, Homma Y.
PMID: 21221199
Korean J Urol. 2010 Dec;51(12):811-8. doi: 10.4111/kju.2010.51.12.811. Epub 2010 Dec 21.

In the present review article, we present an overview of beta-adrenoceptor (β-AR) subtype expression at the mRNA and receptor protein levels in the human detrusor, the in vitro and in vivo bladder function of the β3-AR, the in vivo...

Cite
Igawa Y, Aizawa N, Homma Y. Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol. 2010;51(12):811-8doi: 10.4111/kju.2010.51.12.811.
Igawa, Y., Aizawa, N., & Homma, Y. (2010). Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean journal of urology, 51(12), 811-8. https://doi.org/10.4111/kju.2010.51.12.811
Igawa, Yasuhiko, et al. "Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder." Korean journal of urology vol. 51,12 (2010): 811-8. doi: https://doi.org/10.4111/kju.2010.51.12.811
Igawa Y, Aizawa N, Homma Y. Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol. 2010 Dec;51(12):811-8. doi: 10.4111/kju.2010.51.12.811. Epub 2010 Dec 21. PMID: 21221199; PMCID: PMC3016425.
Copy Download .nbib Format: NLM
Function and dysfunction of human sinoatrial node.

Korean circulation journal

Joung B, Chen PS.
PMID: 26023305
Korean Circ J. 2015 May;45(3):184-91. doi: 10.4070/kcj.2015.45.3.184. Epub 2015 May 27.

Sinoatrial node (SAN) automaticity is jointly regulated by a voltage (cyclic activation and deactivation of membrane ion channels) and Ca(2+) clocks (rhythmic spontaneous sarcoplasmic reticulum Ca(2+) release). Using optical mapping in Langendorff-perfused canine right atrium, we previously demonstrated that...

Cite
Joung B, Chen PS. Function and dysfunction of human sinoatrial node. Korean Circ J. 2015;45(3):184-91doi: 10.4070/kcj.2015.45.3.184.
Joung, B., & Chen, P. S. (2015). Function and dysfunction of human sinoatrial node. Korean circulation journal, 45(3), 184-91. https://doi.org/10.4070/kcj.2015.45.3.184
Joung, Boyoung, and Chen, Peng-Sheng. "Function and dysfunction of human sinoatrial node." Korean circulation journal vol. 45,3 (2015): 184-91. doi: https://doi.org/10.4070/kcj.2015.45.3.184
Joung B, Chen PS. Function and dysfunction of human sinoatrial node. Korean Circ J. 2015 May;45(3):184-91. doi: 10.4070/kcj.2015.45.3.184. Epub 2015 May 27. PMID: 26023305; PMCID: PMC4446811.
Copy Download .nbib Format: NLM
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.

Circulation

Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M.
PMID: 34806902
Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22.

BACKGROUND: Remodeling of the extracellular matrix (ECM) is a hallmark of heart failure (HF). Our previous analysis of the secretome of murine cardiac fibroblasts returned ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) as one of the most...

Cite
Barallobre-Barreiro J, Radovits T, Fava M, et al. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021;144(25):2021-2034doi: 10.1161/CIRCULATIONAHA.121.055732.
Barallobre-Barreiro, J., Radovits, T., Fava, M., Mayr, U., Lin, W. Y., Ermolaeva, E., Martínez-López, D., Lindberg, E. L., Duregotti, E., Daróczi, L., Hasman, M., Schmidt, L. E., Singh, B., Lu, R., Baig, F., Siedlar, A. M., Cuello, F., Catibog, N., Theofilatos, K., Shah, A. M., Crespo-Leiro, M. G., Doménech, N., Hübner, N., Merkely, B., & Mayr, M. (2021). Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation, 144(25), 2021-2034. https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro, Javier, et al. "Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling." Circulation vol. 144,25 (2021): 2021-2034. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055732
Barallobre-Barreiro J, Radovits T, Fava M, Mayr U, Lin WY, Ermolaeva E, Martínez-López D, Lindberg EL, Duregotti E, Daróczi L, Hasman M, Schmidt LE, Singh B, Lu R, Baig F, Siedlar AM, Cuello F, Catibog N, Theofilatos K, Shah AM, Crespo-Leiro MG, Doménech N, Hübner N, Merkely B, Mayr M. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021 Dec 21;144(25):2021-2034. doi: 10.1161/CIRCULATIONAHA.121.055732. Epub 2021 Nov 22. PMID: 34806902; PMCID: PMC8687617.
Copy Download .nbib Format: NLM
Beta-adrenergic blocking drugs in breast cancer: a perspective review.

Therapeutic advances in medical oncology

Barron TI, Sharp L, Visvanathan K.
PMID: 22590485
Ther Adv Med Oncol. 2012 May;4(3):113-25. doi: 10.1177/1758834012439738.

The purpose of this review is to present the preclinical, epidemiological and clinical data relevant to the association between β-blockers and breast cancer progression. Preclinical studies have shown that β-adrenergic receptor (β-AR) signalling can inhibit multiple cellular processes involved...

Cite
Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol. 2012;4(3):113-25doi: 10.1177/1758834012439738.
Barron, T. I., Sharp, L., & Visvanathan, K. (2012). Beta-adrenergic blocking drugs in breast cancer: a perspective review. Therapeutic advances in medical oncology, 4(3), 113-25. https://doi.org/10.1177/1758834012439738
Barron, Thomas I, et al. "Beta-adrenergic blocking drugs in breast cancer: a perspective review." Therapeutic advances in medical oncology vol. 4,3 (2012): 113-25. doi: https://doi.org/10.1177/1758834012439738
Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol. 2012 May;4(3):113-25. doi: 10.1177/1758834012439738. PMID: 22590485; PMCID: PMC3349076.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries